Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_194Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 173Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI90% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_195Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 173Desnity of 5000 cells per wellNAUptiBlue assay1 MOI80% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_196Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 173Desnity of 5000 cells per wellNAUptiBlue assay10 MOI30% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_197Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 31Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_198Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 31Desnity of 5000 cells per wellNAUptiBlue assay1 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_199Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 31Desnity of 5000 cells per wellNAUptiBlue assay10 MOI1% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_200Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 35Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI52% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_201Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 35Desnity of 5000 cells per wellNAUptiBlue assay1 MOI25% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_202Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 35Desnity of 5000 cells per wellNAUptiBlue assay10 MOI10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_203Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 36Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI55% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_204Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 36Desnity of 5000 cells per wellNAUptiBlue assay1 MOI32% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_205Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 36Desnity of 5000 cells per wellNAUptiBlue assay10 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_206Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 37Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI55% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_207Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 37Desnity of 5000 cells per wellNAUptiBlue assay1 MOI32% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_208Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 37Desnity of 5000 cells per wellNAUptiBlue assay10 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_209Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 47Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI48% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_210Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 47Desnity of 5000 cells per wellNAUptiBlue assay1 MOI10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_211Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 47Desnity of 5000 cells per wellNAUptiBlue assay10 MOI4% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_212Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 56Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI80% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_213Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 56Desnity of 5000 cells per wellNAUptiBlue assay1 MOI52% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_214Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 56Desnity of 5000 cells per wellNAUptiBlue assay10 MOI18% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_215Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 76Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI90% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_216Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 76Desnity of 5000 cells per wellNAUptiBlue assay1 MOI60% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_217Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 76Desnity of 5000 cells per wellNAUptiBlue assay10 MOI20% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_218Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 96Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI30% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_219Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 96Desnity of 5000 cells per wellNAUptiBlue assay1 MOI12% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_220Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 96Desnity of 5000 cells per wellNAUptiBlue assay10 MOI4% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_221Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 152Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI49% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_222Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 152Desnity of 5000 cells per wellNAUptiBlue assay1 MOI25% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_223Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 152Desnity of 5000 cells per wellNAUptiBlue assay10 MOI8% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_224Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 225Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI30% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_225Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 225Desnity of 5000 cells per wellNAUptiBlue assay1 MOI16% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_226Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 225Desnity of 5000 cells per wellNAUptiBlue assay10 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_227Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 13Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI50% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_228Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 13Desnity of 5000 cells per wellNAUptiBlue assay1 MOI25% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_229Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 13Desnity of 5000 cells per wellNAUptiBlue assay10 MOI4% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_230Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 34Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI60% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_231Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 34Desnity of 5000 cells per wellNAUptiBlue assay1 MOI30% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_232Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 34Desnity of 5000 cells per wellNAUptiBlue assay10 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_233Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 122Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI75% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_234Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 122Desnity of 5000 cells per wellNAUptiBlue assay1 MOI25% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_235Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 122Desnity of 5000 cells per wellNAUptiBlue assay10 MOI4% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_236Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 11Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI75% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_237Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 11Desnity of 5000 cells per wellNAUptiBlue assay1 MOI60% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_238Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 11Desnity of 5000 cells per wellNAUptiBlue assay10 MOI32% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_239Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 163Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI75% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_240Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 163Desnity of 5000 cells per wellNAUptiBlue assay1 MOI40% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_241Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 163Desnity of 5000 cells per wellNAUptiBlue assay10 MOI10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_242Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 4Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI85% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_243Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 4Desnity of 5000 cells per wellNAUptiBlue assay1 MOI78% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_244Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 4Desnity of 5000 cells per wellNAUptiBlue assay10 MOI35% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_245Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 45Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI110% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_246Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 45Desnity of 5000 cells per wellNAUptiBlue assay1 MOI90% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_247Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 45Desnity of 5000 cells per wellNAUptiBlue assay10 MOI10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_248Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 52Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI100% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_249Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 52Desnity of 5000 cells per wellNAUptiBlue assay1 MOI95% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_250Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 52Desnity of 5000 cells per wellNAUptiBlue assay10 MOI70% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_251Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 61Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI80% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_252Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 61Desnity of 5000 cells per wellNAUptiBlue assay1 MOI50% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_253Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 61Desnity of 5000 cells per wellNAUptiBlue assay10 MOI12% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_254Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 95Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI42% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_255Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 95Desnity of 5000 cells per wellNAUptiBlue assay1 MOI22% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_256Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 95Desnity of 5000 cells per wellNAUptiBlue assay10 MOI8% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_257Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 150Desnity of 5000 cells per wellNAUptiBlue assay0.1 MOI40% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_258Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 150Desnity of 5000 cells per wellNAUptiBlue assay1 MOI30% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_259Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneYesNoNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 150Desnity of 5000 cells per wellNAUptiBlue assay10 MOI10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_260Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 4Desnity of 5000 cells per wellNAUptiBlue assay1 MOI90% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_261Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 31Desnity of 5000 cells per wellNAUptiBlue assay1 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_262Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 35Desnity of 5000 cells per wellNAUptiBlue assay1 MOI8% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_263Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 37Desnity of 5000 cells per wellNAUptiBlue assay1 MOI25% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_264Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 152Desnity of 5000 cells per wellNAUptiBlue assay1 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_265Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 13Desnity of 5000 cells per wellNAUptiBlue assay1 MOI5% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_266Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 11Desnity of 5000 cells per wellNAUptiBlue assay1 MOI49% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_267Measles virusSchwarz and Edmonston MV strainRNAParamyxoviridaeNoneNoVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virusNoNAMalignant pleural mesothelioma (MPM) cell lineMeso 163Desnity of 5000 cells per wellNAUptiBlue assay1 MOI45% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)NoNoNA No responseNANANANA26539644
OV_858Measles virusMV-EdmRNAParamyxoviridaeRecombinant expressing a peptideYesNovirus expressing a marker peptide (MV-hCEA)NaturalNANANANANANANAFemale athymic mouse xenograft model for SKOV3 cell line1.0E+7 pfu/mlNA Median survival time increased by >105 dayssubcutaneousNANANA12183422
OV_859Measles virusMV-EdmRNAParamyxoviridaeRecombinant expressing a peptideYesNovirus expressing a marker peptide (MV-hCEA)NaturalNANANANANANANAFemale athymic mouse xenograft model for SKOV3 cell line10⁷pfu/mlNA Median survival time increased by >80 daysintraperitonialNANANA12183422
OV_1667Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1668Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1669Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1670Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1671Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1672Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1673Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1674Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1675Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1676Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI70% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1677Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1678Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1679Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1680Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1681Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI50% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1682Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1683Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1684Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1685Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1686Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1687Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1688Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1689Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1690Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938